Enovix Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Enovix Corporation on April 17, 2025. The report discloses the appointment of a new Chief Financial Officer (CFO) effective April 14, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Ryan Benton as Chief Financial Officer, effective April 14, 2025. Mr. Benton previously served as CFO of Silvaco Group, Inc. (August 2023–April 2025), Tempo Automation, Revasum, and BrainChip Holdings Ltd.
Management Commentary and Compensation Details
- Base Salary: $425,000 annually.
- Annual Bonus: Discretionary cash bonus with a target of 60% of base salary, contingent on performance goals.
- Equity Grant: Restricted Stock Units (RSUs) with a fair market value of $4,500,000 as of the commencement date.
- Vesting Schedule: 20% vests after 12 months; the remaining 80% vests quarterly over the subsequent four years, subject to continued service.
- Severance Provisions: In the event of termination without Cause or resignation for Good Reason (outside of a Change of Control), Mr. Benton is eligible for nine months of base salary, nine months of health care coverage, a pro-rated bonus, and accelerated vesting of certain equity awards. Additional accelerated vesting applies in connection with a Change of Control.
Investor Verification Checklist
- Verify the full text of the Employment Agreement, which is expected to be filed as an exhibit to the next Form 10-Q.
- Confirm the specific performance goals tied to the annual discretionary bonus.
- Review the terms of the 2021 Equity Incentive Plan referenced for the RSU grant.
- Monitor future filings for any changes to the executive team or compensation structure.